UniQure halves research, lays off 20% while CSO departs in major revamp
US and Dutch gene therapy maker uniQure will undergo a broad overhaul that includes laying off 20% of its workforce, the departure of its chief …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
